User:Mr. Ibrahem/Erenumab

Erenumab, sold under the brand name Aimovig, is a medication used to prevent migraine headaches. It is used in those who have at least 4 headaches a month. It is given by injection under the skin.

Common side effects include constipation and muscle spasms. Other side effects may include swelling due to fluid retention. While there is no evidence of harm with use in prenancy, such use has not been well studied. It is a monoclonal antibody that binds to and blocks calcitonin gene-related peptide receptor (CGRPR).

Erenumab was approved for medical use in the United States and Europe in 2018. In the United Kingdom it costs about £390 every 4 weeks as of 2021. This amount in the United States is about 630 USD.